| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |